CLU and myocardial ischemia: Glycosylation, a key post-translational modification of the ApoJ protein, influences its function, with lower levels of glycosylated ApoJ (ApoJ-Glyc) observed during acute ischemic events, suggesting its potential as a myocardial ischemia biomarker [34,35].